Digital cognitive impairment assessment tool earns validation
By
Donna Shryer
Aug 06, 2024
New research presented at the Alzheimer’s Association International Conference (AAIC) provided validation for BrainCheck, a digital cognitive assessment tool. Researchers from the University of Washington...
More news for Wednesday, Aug. 7, 2024
By
Kimberly Bonvissuto
Aug 07, 2024
American Healthcare REIT ‘off to a great start’ as publicly listed company … Life plan community first to achieve Purple Flag for Dementia Care reaccreditation … Capstone project outlines challenges,...
CDC presents characteristics of residential care community residents
Aug 07, 2024
75% needed assistance with bathing, 71% with walking and 62% with three or more activities of daily living.
COVID-19 continues to affect leading causes of death in US: CDC
By
Kimberly Bonvissuto
Aug 12, 2024
The COVID-19 pandemic radically altered the rankings of the leading causes of death in the United States in 2020, and although COVID ranks lower on the list of causes in 2023, its effects continue to be...
Alzheimer’s care, quality of life improve with innovative immersion room
By
Jessica R. Towhey
Aug 05, 2024
A creative new room at a Long Island, NY, nursing home may serve as a model for improving the quality of Alzheimer’s care.
What happens if biomarker tests spot Alzheimer’s before people show symptoms?
By
Kristen Fischer
Aug 05, 2024
As of now, no therapy is approved by the Food and Drug Administration for people at risk of Alzheimer’s disease who don’t have symptoms. But blood tests that can spot biomarkers linked to the disease...
CDC releases new profile of assisted living residents
By
Kimberly Bonvissuto
Aug 09, 2024
Residents living in assisted living and other residential care communities in 2022 mostly were female (67%), white (92%) and 85 or older (53%), according to a new report from the Centers for Disease Control...
Plasma biomarkers of Alzheimer’s neuropathy linked to dementia risk
Aug 01, 2024
Significant associations were seen for all Alzheimer’s disease plasma biomarkers in late life with late-life dementia.
Population-level interventions cost-effective for reducing risk for dementia
Aug 01, 2024
The interventions could reduce the risk factors for dementia, resulting in a cost-savings and a gain in quality-adjusted life years.